Name: The 4th International Electronic Conference on Cancers
Start: 2024-03-06T00:00:00
End: 2024-03-08T00:00:00

Program Overview

IECC 2024 Program

Click here to register for IECC 2024 for free! The registration includes attendance to all conference sessions.

6 March 2024 (Wednesday)
_{Session G. Cancer Therapy}

CET (Central European Time - UTC+1)	CST Asia (China Standard Time - UTC+8)	Speaker	Title
9:00-9:15	16:00-16:15	Welcome from the conference chair- Dr. Shinji Kawabata and the session chair-Dr. Ulrich Pfeffer
9:15-9:35	16:15-16:35	Invited Speaker Michela Croce	Epigenetic drugs to improve efficacy of immune checkpoint blocker therapy
9:35-9:55	16:35-16:55	Invited Speaker Giovanni Nassa	Targeting chromatin remodelers to overcome endocrine therapy resistance in breast cancer
9:55-10:10	16:55-17:10	Selected Speaker Yoshiki Fujikawa	Exploring BNCT as a Novel Approach for Metastatic Spinal Tumor Management
10:10-10:25	17:10-17:25	Selected Speaker Kohei Tsujino	Evaluation of the safety of folate receptor-targeted boron carrier in boron neutron capture therapy (BNCT) for malignant gliomas using CED administration

6 March 2024 (Wednesday)
_{Session H. Cancer Pathophysiology}

CET (Central European Time - UTC+1)	CST Asia (China Standard Time - UTC+8)	Speaker	Title
15:00-15:10	22:00-22:10	Welcome from session chairs - Prof. Nicola Amodio and Prof. Giuseppe Viglietto
15:10-15:30	22:10-22:30	Invited Speaker Annamaria Gullà	Dissecting the path to immunogenic chemotherapy in multiple myeloma
15:30-15:50	22:30-22:50	Invited Speaker Bruno Simoes	Targeting cancer stem cells in hormone-resistant breast cancer
15:50-16:10	22:50-23:10	Invited Speaker Giuseppina Augimeri	A hybrid cell population generated through engulfment of mesenchymal stem cell by breast cancer cells enhances chemoresistance and metastasis
16:10-16:20	23:10-23:20	Break
16:20-16:40	23:20-23:40	Invited Speaker Marilena V Iorio	ncRNA deregulation as a flag of drug resistance in HER2-positive breast cancer
16:40-17:00	23:40-00:00	Invited Speaker Cirino Botta	The Dynamic myeloma microenvironment: implications for cancer evolution and therapy resistance
17:00-17:20	00:00-00:20	Invited Speaker Zachary R. Hunter	Multi-omic Analysis of Clonal Evolution and the Subtypes of Waldenstrom's Macroglobulinemia
17:20-17:35	00:20-00:35	Selected Speaker Valentina Serratore	Deciphering the role of USP16 in lung cancer

7 March 2024 (Thursday)
_{Session C. Cancer Immunology and Immunotherapy}

CET (Central European Time - UTC+1)	CST Asia (China Standard Time - UTC+8)	Speaker	Title
8:00-8:05	15:00-15:05	Welcome from session chair - Prof. Dr. Vasso Apostolopoulos
8:05-8:25	15:05-15:25	Keynote Speaker Magdalena Plebanski	Personalised immunotherapy and earlier diagnosis in ovarian cancer
8:25-8:40	15:25-15:40	Invited Speaker John Trant	Cancer Immunotherapy three ways
8:40-8:55	15:40-15:55	Invited Speaker Rajamaran Eri	ROLE OF NLRP3 INFLAMMASOME COLITIS-ASSOCIATED COLORECTAL CANCER
8:55-9:10	15:55-16:10	Selected Speaker Nyanbol Kuol	Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines
9:10-9:20	16:10-16:20	Break
9:20-9:35	16:20-16:35	Invited Speaker Andreas Tzakos	Targeting Gliomas
9:35-9:50	16:35-16:50	Invited Speaker George Alexiou	NEW THERAGNOSTIC AGENT AGAINST GLIOMA BASED ON GEMCITABINE
9:50-10:05	16:50-17:05	Invited Speaker Vivek Chavda	CAR T‑Cell therapy for the management of mantle cell lymphoma
10:05-10:20	17:05-17:20	Selected Speaker Ramya Ephraim	Differential Gene Expression of Checkpoint Markers and Cancer Markers in Mouse Models of Spontaneous Chronic Colitis

7 March 2024 (Thursday)
_{Session B. Cancer Biomarkers}

CET (Central European Time - UTC+1)	CST Asia (China Standard Time - UTC+8)	Speaker	Title
15:00-15:05	22:00-22:10	Welcome from session chair - Prof. Dr. Mario Capasso
15:05-15:25	22:05-22:25	Invited Speaker Ramin Massoumi	Unlocking the Future of Lung Cancer Treatment: Biomarkers and Preclinical Insights
15:25-15:40	22:25-22:40	Selected Speaker Ella Markalunas	Correlational Analysis of Genetic Mutations and Galectin Levels in Breast Cancer Patients
15:40-15:55	22:40-22:55	Selected Speaker Alejandro Cepero	Predictive Value of FDG PET Radiomics for Early Response to Chemoradiation in Locally Advanced Cervical Cancer
15:55-16:05	22:55-23:05	Break
16:05-16:20	23:05-23:20	Invited Speaker Schleiermacher Gudrun	Predictive biomarkers in pediatric oncology - the role of clonal evolution studied by sequential cfDNA
16:20-16:40	23:20-23:40	Invited Speaker Banafshé Larijani	The fusion of quantitative molecular proteomics and immune-oncology: a step towards precision medicine in cancer therapeutic.
16:40-16:45	23:40-23:45	Session Chair Professor Stephen Geoffrey Ward	Closing Speech

8 March 2024 (Friday)
_{Poster Session}

_{The list of names and titles are the posters can be found here.}

CET (Central European Time - UTC+1)	CST Asia (China Standard Time - UTC+8)	Speaker	Title
9:00 - 11:00	16:00 - 18:00	Poster Session	The Poster Session will take place in Zoom breakout rooms.

8 March 2024 (Friday)
_{Session D. Tumor Microenvironment}

_{Session E. Molecular Cancer Biology}

_{Session F. Cancer Epidemiology and Prevention}

CET (Central European Time - UTC+1)	CST Asia (China Standard Time - UTC+8)	Speaker	Title
15:00-15:05	22:00-22:10	Welcome from session chair - Prof. Dr. Robert-Alain Toillon
15:05-15:25	22:05-22:25	Invited Speaker Prof. Dr. Robert-Alain Toillon	Microenvironment and Breast Cancer
15:25-15:40	22:25-22:40	Selected Speaker Kamila Wolnica	Infrared molecular responce of craniofacial squamous cell carcinoma - pilot study
15:40-15:55	22:40-22:55	Selected Speaker Vincenzo Aievola	Noncoding regulatory mutations as a driving event for the oncogenic core regulatory circuitries of neuroblastoma
15:55-16:10	22:55-23:10	Selected Speaker Teresa Maiorino	Post-GWAS functional analysis of the 11p11.2 risk locus identifies HSD17B12 as a neuroblastoma susceptibility gene involved in lipid metabolism
16:10-16:25	23:10-23:25	Selected Speaker Maciej Maciejczyk	Polycyclic aromatic hydrocarbons (PAHs) in grilled marshmallows
16:25-16:40	23:25-23:40	Selected Speaker Maria Victoria Niklison-Chirou	Suppression of Medulloblastoma Cell Migration by clinically Significant Doses of Simvastatin through Mevalonate Pathway Targeting
16:40-16:55	23:40-23:55	Selected Speaker Cameron K Tebbi	Exposure to mycovirus-containing Aspergillus flavus alters transcription factors in normal and leukemia cell lines

IECC2024

Disclaimer